Andressa Keiko Matsumoto

Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson’s disease and its progression: Disease and staging biomarkers and new drug targets

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · Neuroscience Letters · 2016 · 128 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Lowered Antioxidant Defenses and Increased Oxidative Toxicity Are Hallmarks of Deficit Schizophrenia: a Nomothetic Network Psychiatry Approach

Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto et al. · Molecular Neurobiology · 2020 · 61 citations · Full text

Medicine, Neuroscience, Psychiatry +15

Increased Levels of Plasma Tumor Necrosis Factor-α Mediate Schizophrenia Symptom Dimensions and Neurocognitive Impairments and Are Inversely Associated with Natural IgM Directed to Malondialdehyde and Paraoxonase 1 Activity

Michaël Maes, Sunee Sirivichayakul, Andressa Keiko Matsumoto et al. · Molecular Neurobiology · 2020 · 58 citations · Full text

Life Sciences, Neuroscience, Psychiatry +7

Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways

Carine Coneglian de Farias, Michaël Maes, Kamila Landucci Bonifácio et al. · CNS & Neurological Disorders - Drug Targets · 2017 · 34 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Activated neuro-oxidative and neuro-nitrosative pathways at the end of term are associated with inflammation and physio-somatic and depression symptoms, while predicting outcome characteristics in mother and baby

Chutima Roomruangwong, Décio Sabbatini Barbosa, Andressa Keiko Matsumoto et al. · Journal of Affective Disorders · 2017 · 34 citations · Full text

Life Sciences, Neuroscience, Obstetrics +16